Oxygenta Pharmaceutical LimitedBSE: OXYGENTAPH

Oxygenta Pharmaceutical Limited Press Release Oct 16 2025

· Issued by Oxygenta Pharmaceutical Limited via BSE India

Filed with BSE ·

Intimation of Receipt of No-objection from BSE Limited (BSE) for reclassification from "Promoter/ Promoter Group" Category to "Public" Category shareholder of the Company pursuant to Regulation 31A of Securities Exchange Board of India (Listing Obligations and Disclsoure Requirements), Regulations, 2015 ("SEBI LODR").

View Attachment

6ix hasn’t read this filing yet.

Oxygenta Pharmaceutical Limited on 6ix

Earlier from Oxygenta Pharmaceutical

Later from Oxygenta Pharmaceutical

All Oxygenta Pharmaceutical news releases